Intestinal absorption mechanisms of berberine, palmatine, jateorhizine, and coptisine: Involvement of P-glycoprotein

Xenobiotica

Volumn 41, Issue 4, 2011, Pages 290-296

  Zhang, Xinfeng ^a   Qiu, Furong ^a   Jiang, Jian ^a   Gao, Chenglu ^a   Tan, Yingzi ^a  

^a SHANGHAI UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

Author keywords

Caco 2 cells; Coptis chinensis; isoquinoline alkaloids; MRP2; P gp; transport

Indexed keywords

BERBERINE; COPTISINE; CYCLOSPORIN A; GLYCOPROTEIN P; MULTIDRUG RESISTANCE PROTEIN 2; PALMATINE; VERAPAMIL; VERLUKAST;

ARTICLE; CELL STRAIN CACO 2; HUMAN; HUMAN CELL; INTESTINE ABSORPTION;

BERBERINE; BERBERINE ALKALOIDS; BIOLOGICAL TRANSPORT; CACO-2 CELLS; CYCLOSPORINE; DRUGS, CHINESE HERBAL; HUMANS; INTESTINAL ABSORPTION; MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS; P-GLYCOPROTEIN; PROPIONATES; QUINOLINES; VERAPAMIL;

COPTIS CHINENSIS;

EID: 79952952269     PISSN: 00498254     EISSN: 13665928     Source Type: Journal    
DOI: 10.3109/00498254.2010.529180     Document Type: Article

References (39)

1. Artursson P, Karlsson J. (1991). Correlation between oral drug absorption in humans and apparent drug permeability coefficients in human intestinal epithelial (Caco-2) cells. Biochem Biophys Res Commun 175:880-885.
2. Bailey CA, Bryla P, Malick AW. (1996). The use of the intestinal epithelial cell culture model, Caco-2, in pharmaceutical development. Adv Drug Deliv Rev 22:85-103. (Pubitemid 26423599)
3. Chinese Pharmacopoeia Commission. (2010). Pharmacopoeia of the People's Republic of China. Volume I (in Chinese). Beijing, China: Chinese Medicinal Science and Technology Press.
4. Cordon-Cardo C, O'Brien JP, Casals D, Rittman-Grauer L, Biedler JL, Melamed MR, Bertino JR. (1989). Multidrug-resistance gene (P-glycoprotein) is expressed by endothelial cells at blood-brain barrier sites. Proc Natl Acad Sci USA 86:695-698. (Pubitemid 19037807)
5. Hayashi K, Minoda K, Nagaoka Y, Hayashi T, Uesato S. (2007). Antiviral activity of berberine and related compounds against human cytomegalovirus. Bioorg Med Chem Lett 17:1562-1564.
6. Inoue K, Kulsum U, Chowdhury SA, Fujisawa S, Ishihara M, Yokoe I, Sakagami H. (2005). Tumor-specific cytotoxicity and apoptosisinducing activity of berberines. Anticancer Res 25:4053-4059. (Pubitemid 41665185)
7. Jia F, Zou G, Fan J, Yuan Z. (2010). Identification of palmatine as an inhibitor of West Nile virus. Arch Virol 155:1325-1329.
8. Kong LD, Cheng CH, Tan RX. (2001). Monoamine oxidase inhibitors from rhizoma of Coptis chinensis. Planta Med 67:74-76. (Pubitemid 32199950)
9. Kuo CL, Chi CW, Liu TY. (2004). The anti-inflammatory potential of berberine in vitro and in vivo. Cancer Lett 203:127-137.
10. Lanvers-Kaminsky C, Nolting DM, Köster J, Schröder A, Sandkötter J, Boos J. (2006). In-vitro toxicity of Ukrain against human Ewing tumor cell lines. Anticancer Drugs 17:1025-1030. (Pubitemid 44454779)
11. Lee CH, Chen JC, Hsiang CY, Wu SL, Wu HC, Ho TY. (2007). Berberine suppresses inflammatory agents-induced interleukin-1beta and tumor necrosis factor-alpha productions via the inhibition of IkappaB degradation in human lung cells. Pharmacol Res 56:193-201.
12. Lin CC, Kao ST, Chen GW, Ho HC, Chung JG. (2006). Apoptosis of human leukemia HL-60 cells and murine leukemia WEHI-3 cells induced by berberine through the activation of caspase-3. Anticancer Res 26:227-242.
13. Lin JP, Yang JS, Chang NW, Chiu TH, Su CC, Lu KW, Ho YT, Yeh CC, Mei-Dueyang, Lin HJ, Chung JG. (2007). GADD153 mediates berberine-induced apoptosis in human cervical cancer Ca ski cells. Anticancer Res 27:3379-3386.
14. Liu F, Ng TB. (2000). Antioxidative and free radical scavenging activities of selected medicinal herbs. Life Sci 66:725-735. (Pubitemid 30077865)
15. Maeng HJ, Yoo HJ, Kim IW, Song IS, Chung SJ, Shim CK. (2002). P-glycoprotein-mediated transport of berberine across Caco-2 cell monolayers. J Pharm Sci 91:2614-2621.
16. Makhey VD, Guo A, Norris DA, Hu P, Yan J, Sinko PJ. (1998). Characterization of the regional intestinal kinetics of drug efflux in rat and human intestine and in Caco-2 cells. Pharm Res 15:1160-1167. (Pubitemid 28401704)
17. Pan GY, Huang ZJ, Wang GJ, Fawcett JP, Liu XD, Zhao XC, Sun JG, Xie YY. (2003). The antihyperglycaemic activity of berberine arises from a decrease of glucose absorption. Planta Med 69:632-636. (Pubitemid 37041059)
18. Pan GY, Wang GJ, Liu XD, Fawcett JP, Xie YY. (2002). The involvement of P-glycoprotein in berberine absorption. Pharmacol Toxicol 91:193-197. (Pubitemid 35216922)
19. Piyanuch R, Sukhthankar M, Wandee G, Baek SJ. (2007). Berberine, a natural isoquinoline alkaloid, induces NAG-1 and ATF3 expression in human colorectal cancer cells. Cancer Lett 258:230-240. (Pubitemid 350110378)
20. Sack RB, Froehlich JL. (1982). Berberine inhibits intestinal secretory response of Vibrio cholerae and Escherichia coli enterotoxins. Infect Immun 35:471-475. (Pubitemid 12164739)
21. Schinella GR, Tournier HA, Prieto JM, Mordujovich de Buschiazzo P, Ríos JL. (2002). Antioxidant activity of anti-inflammatory plant extracts. Life Sci 70:1023-1033. (Pubitemid 34085094)
22. Seithel A, Karlsson J, Hilgendorf C, Björquist A, Ungell AL. (2006). Variability in mRNA expression of ABC- and SLC-transporters in human intestinal cells: Comparison between human segments and Caco-2 cells. Eur J Pharm Sci 28:291-299. (Pubitemid 44218740)
23. Serafim TL, Oliveira PJ, Sardao VA, Perkins E, Parke D, Holy J. (2008). Different concentrations of berberine result in distinct cellular localization patterns and cell cycle effects in a melanoma cell line. Cancer Chemother Pharmacol 61:1007-1018. (Pubitemid 351423129)
24. Shen MP, Sun Q, Wang H. (1993). Studies on the intravenous pharmacokinetics and oral absorption of berberine HCl in beagle dogs. Chin Pharmacol Bull 9:64-67. (Pubitemid 23160416)
25. Taylor CE, Greenough WB 3rd. (1989). Control of diarrheal diseases. Annu Rev Public Health 10:221-244. (Pubitemid 19137980)
26. Turner N, Li JY, Gosby A, To SW, Cheng Z, Miyoshi H, Taketo MM, Cooney GJ, Kraegen EW, James DE, Hu LH, Li J, Ye JM. (2008). Berberine and its more biologically available derivative, dihydroberberine, inhibit mitochondrial respiratory complex I: A mechanism for the action of berberine to activate AMP-activated protein kinase and improve insulin action. Diabetes 57:1414-1418.
27. USFDA. (2006). Draft Guidance for Industry: Drug Interaction Studies- Study Design, Data Analysis, and Implications for Dosing and Labeling, U.S. Food and Drug Administration Publication.
28. Varinska L, Mirossay L, Mojzisova G, Mojzis J. (2010). Antiangiogenic effect of selected phytochemicals. Pharmazie 65:57-63.
29. Wang S, Zheng Z, Weng Y, Yu Y, Zhang D, Fan W, Dai R, Hu Z. (2004). Angiogenesis and anti-angiogenesis activity of Chinese medicinal herbal extracts. Life Sci 74:2467-2478. (Pubitemid 38324603)
30. Xin HW, Wu XC, Li Q, Yu AR, Ulrich Klotz. (2007). Effects of berberine on the transport of P-gp substrates across Caco-2 and L-MDR1 cell monolayers. Chin Pharmacol Bull 23:799-803.
31. Yan D, Jin C, Xiao XH, Dong XP. (2008). Antimicrobial properties of berberines alkaloids in Coptis chinensis Franch by microcalorimetry. J Biochem Biophys Methods 70:845-849.
32. Yang HT, Wang GJ. (2003). Transport and uptake characteristics of a new derivative of berberine (CPU-86017) by human intestinal epithelial cell line: Caco-2. Acta Pharmacol Sin 24:1185-1191. (Pubitemid 37509422)
33. Yin J, Gao Z, Liu D, Liu Z, Ye J. (2008). Berberine improves glucose metabolism through induction of glycolysis. Am J Physiol Endocrinol Metab 294:E148-E156.
34. Yin J, Hu R, Chen M, Tang J, Li F, Yang Y, Chen J. (2002). Effects of berberine on glucose metabolism in vitro. Metab Clin Exp 51:1439-1443.
35. Yu FS, Yang JS, Lin HJ, Yu CS, Tan TW, Lin YT, Lin CC, Lu HF, Chung JG. (2007). Berberine inhibits WEHI-3 leukemia cells in vivo. In Vivo 21:407-412.
36. Yu S, Zhang H, PanJun F, Hong Y, Ren J, Zhu D, and Xu X. (2000). Determination and preliminary studies of metabolism of berberine in human urine after oral administration. Chin J Clin Pharmacol 16:36-39.
37. Yuan L, Tu D, Ye X, Wu J. (2006). Hypoglycemic and hypocholesterolemic effects of Coptis chinensis franch inflorescence. Plant Foods Hum Nutr 61:139-144. (Pubitemid 44554870)
38. Zhou L, Yang Y, Wang X, Liu S, Shang W, Yuan G, Li F, Tang J, Chen M, Chen J. (2007). Berberine stimulates glucose transport through a mechanism distinct from insulin. Metab Clin Exp 56:405-412. (Pubitemid 46209231)
39. Zuo F, Nakamura N, Akao T, Hattori M. (2006). Pharmacokinetics of berberine and its main metabolites in conventional and pseudo germ-free rats determined by liquid chromatography/ion trap mass spectrometry. Drug Metab Dispos 34:2064-2072. (Pubitemid 44837767)